Howa Yeung is a Dermatology physician affiliated with Emory University. OpenAlex indexes 222 publications with 3,535 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1525 Clifton Rd NE
Atlanta, GA 303224200
Telephone
404-778-3333Registry record last updated 9 Jun 2017.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20257 payments
- Lilly USA, LLCProgram year20251 payment
- Lilly USA, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
46.1%Corticosteroid18.8%Triamcinolone Acetonide100%Part D≥35 patientsInterleukin-4 Receptor alpha Antagonist16%Dupixent Syringe61%Dupixent Pen39%Part D<11 patients+ 2 more classes in this area
Sensory organs
18.3%Corticosteroid18.3%Hydrocortisone66%Clobetasol Propionate34%Part D≥31 patientsAnti-infectives
17.5%Azole Antifungal9.3%Ketoconazole100%Part D≥13 patientsLincosamide Antibacterial4.9%Clindamycin Phosphate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Epidemiology, impact, and experience of acne in transgender persons
Emory University
FY2024$157,788K23AR075888 - Epidemiology, impact, and experience of acne in transgender persons
Emory University
FY2023$157,788K23AR075888 - Epidemiology, impact, and experience of acne in transgender persons
Emory University
FY2022$157,788K23AR075888
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Guidelines of care for the management of acne vulgaris
Journal of the American Academy of Dermatology
2024 - Multichannel Healthcare: Impact of Asynchronous Telemedicine Adoption on Patient Flow
Manufacturing & Service Operations Management
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Guyton, MD
Emory University
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”